共 50 条
- [1] ARE COMPLETION RATES BETTER FOR NEOADJUVANT COMPARED TO ADJUVANT CHEMOTHERAPY IN PATIENTS UNDERGOING RADICAL CYSTECTOMY. JOURNAL OF UROLOGY, 2010, 183 (04): : E660 - E660
- [2] AN EVALUATION OF NEOADJUVANT CHEMOTHERAPY ELIGIBILITY RATES AMONG PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER JOURNAL OF UROLOGY, 2012, 187 (04): : E704 - E705
- [4] CHANGES IN BODY COMPOSITION FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY JOURNAL OF UROLOGY, 2024, 211 (05): : E720 - E721
- [7] ELIGIBILITY FOR NEOADJUVANT/ADJUVANT CISPLATIN-BASED CHEMOTHERAPY AMONG RADICAL CYSTECTOMY PATIENTS JOURNAL OF UROLOGY, 2013, 189 (04): : E529 - E529
- [9] IMPACT OF NEOADJUVANT CHEMOTHERAPY ON PATHOLOGIC DOWNSTAGING IN PATIENTS WITH VARIANT HISTOLOGY UNDERGOING RADICAL CYSTECTOMY JOURNAL OF UROLOGY, 2021, 206 : E906 - E906